Vasopressin in Hemorrhagic Shock: A Systematic Review and Meta-Analysis of Randomized Animal Trials

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Cossu, Andrea Pasquale ^a   Mura, Paolo ^a   De Giudici, Lorenzo Matteo ^a   Puddu, Daniela ^a   Pasin, Laura ^b   Evangelista, Maurizio ^c   Xanthos, Theodoros ^d   Musu, Mario ^a   Finco, Gabriele ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARGIPRESSIN; NORADRENALIN; PLACEBO; TERLIPRESSIN; LYPRESSIN; VASOCONSTRICTOR AGENT;

BLOOD PRESSURE; CONTROLLED STUDY; FLUID RESUSCITATION; HEMORRHAGIC SHOCK; META ANALYSIS; MORTALITY; NONHUMAN; REVIEW; SURVIVAL; SYSTEMATIC REVIEW; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; HUMAN; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHOCK; SHOCK, HEMORRHAGIC;

ANIMALIA;

ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; HUMANS; LYPRESSIN; NOREPINEPHRINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOCK; SHOCK, HEMORRHAGIC; VASOCONSTRICTOR AGENTS;

EID: 84925593697     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/421291     Document Type: Review

References (64)

1. W. G. Voelckel, C. Raedler, V. Wenzel et al., "Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs, " Critical Care Medicine, vol. 31, no. 4, pp. 1286-1287, 2003.
2. W. C. Shoemaker, A. B. Peitzman, R. Bellamy et al., "Resuscitation from severe hemorrhage, " Critical Care Medicine, vol. 24, no. 2, pp. S12-S23, 1996.
3. B. Bayram, N. Hocaoglu, R. Atilla, and S. Kalkan, "Effects of terlipressin in a rat model of severe uncontrolled hemorrhage via liver injury, " The American Journal of Emergency Medicine, vol. 30, no. 7, pp. 1176-1182, 2012.
4. H. P. Santry and H. B. Alam, "Fluid resuscitation: past, present, and the future, " Shock, vol. 33, no. 3, pp. 229-241, 2010.
5. A. T. W. Cheung, P. L. To, D. M. Chan et al., "Comparison of treatment modalities for hemorrhagic shock, " Artificial Cells, Blood Substitutes, and Biotechnology, vol. 35, no. 2, pp. 173-190, 2007.
6. K. H. Stadlbauer, H. G. Wagner-Berger, V. Wenzel et al., "Survival with full neurologic recovery after prolonged cardiopulmonary resuscitation with a combination of vasopressin and epinephrine in pigs, " Anesthesia and Analgesia, vol. 96, no. 6, pp. 1743-1749, 2003.
7. F. G. Bonanno, "Hemorrhagic shock: the "physiology approach", " Journal of Emergencies, Trauma and Shock, vol. 5, no. 4, pp. 285-295, 2012.
8. A. J. Feinstein, M. B. Patel, M. Sanui, S. M. Cohn, M. Majetschak, and K. G. Proctor, "Resuscitation with pressors after traumatic brain injury, " Journal of the American College of Surgeons, vol. 201, no. 4, pp. 536-545, 2005.
9. Y. Fang, T. Li, X. Fan, Y. Zhu, and L. Liu, "Beneficial effects of activation of PKC on hemorrhagic shock in rats, " The Journal of Trauma, Injury, Infection and Critical Care, vol. 68, no. 4, pp. 865-873, 2010.
10. C. Raedler, W. G. Voelckel, V. Wenzel et al., "Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin, " Anesthesia and Analgesia, vol. 98, no. 6, pp. 1759-1766, 2004.
11. T. Li, Y. Fang, Y. Zhu et al., "A small dose of arginine vasopressin in combination with norepinephrine is a good early treatment for uncontrolled hemorrhagic shock after hemostasis, " Journal of Surgical Research, vol. 169, no. 1, pp. 76-84, 2011.
12. W. H. Bickell, M. J. Wall Jr., P. E. Pepe et al., "Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries, "TheNew England Journal ofMedicine, vol. 331, no. 17, pp. 1105-1109, 1994.
13. P. Meybohm, E. Cavus, B. Bein et al., "Small volume resuscitation: arandomized controlled trial with either norepinephrine or vasopressin during severe hemorrhage, " Journal of Trauma: Injury Infection & Critical Care, vol. 62, no. 3, pp. 640-646, 2007.
14. W. G. Voelckel, V. A. Convertino, K. G. Lurie et al., "Vasopressin for hemorrhagic shock management: Revisiting the potential value in civilian and combat casualty care, " Journal of Trauma, vol. 69, no. 1, pp. S69-S74, 2010.
15. D. R. Spahn, B. Bouillon, V. Cerny et al., "Management of bleeding and coagulopathy followingmajor trauma: an updated European guideline, " Critical Care, vol. 17, no. 2, article R76, 2013.
16. N. F. Holt and K. L. Haspel, "Vasopressin: a Review of Therapeutic Applications, " Journal of Cardiothoracic and Vascular Anesthesia, vol. 24, no. 2, pp. 330-347, 2010.
17. L. Bankir, "Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects, " Cardiovascular Research, vol. 51, no. 3, pp. 372-390, 2001.
18. J.-L. Vincent and F. Su, "Physiology and pathophysiology of the vasopressinergic system, " Best Practice and Research: Clinical Anaesthesiology, vol. 22, no. 2, pp. 243-252, 2008.
19. R. Moreau, E. Barriere, K. A. Tazi et al., "Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis, " Hepatology, vol. 36, no. 5, pp. 1070-1078, 2002.
20. V. Wenzel and K. H. Lindner, "Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor, " Cardiovascular Research, vol. 51, no. 3, pp. 529-541, 2001.
21. M. Sanui, D. R. King, A. J. Feinstein, A. J. Varon, S. M. Conn, and K. G. Proctor, "Effects of arginine vasopressin during resuscitation from hemorrhagic hypotension after traumatic brain injury, " Critical CareMedicine, vol. 34, no. 2, pp. 433-438, 2006.
22. S. Rehberg, C. Ertmer, M. Lange et al., "Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study, " Critical Care, vol. 14, no. 6, article R200, 2010.
23. R. P. Dellinger, M. M. Levy, A. Rhodes et al., "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012, " vol. 41, no. 2, pp. 580-637, 2013.
24. A. Delmas, M. Leone, S. Rousseau, J. Albanese, and C. Martin, "Clinical review: vasopressin and terlipressin in septic shock patients, " Critical Care, vol. 9, no. 2, pp. 212-222, 2005.
25. K. B. Johnson, F. J. Pearce, N. Jeffreys, S. W. McJames, and M. Cluff, "Impact of Vasopressin on Hemodynamic andMetabolic Function in the Decompensatory Phase of Hemorrhagic Shock, " Journal of Cardiothoracic and Vascular Anesthesia, vol. 20, no. 2, pp. 167-172, 2006.
26. W. G. Voelckel, K. G. Lurie, K. H. Lindner et al., "Vasopressin improves survival after cardiac arrest in hypovolemic shock, " Anesthesia and Analgesia, vol. 91, no. 3, pp. 627-634, 2000.
27. T. Haas, W. G. Voelckel, F. Wiedermann, V. Wenzel, and K. H. Lindner, "Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shockwith vasopressin: a case report and brief review of the literature., "The Journal of Trauma, vol. 57, no. 1, pp. 177-179, 2004.
28. D. Morales, J. Madigan, S. Cullinane et al., "Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock, " Circulation, vol. 100, no. 3, pp. 226-229, 1999.
29. V. Wenzel, A. C. Krismer, H. R. Arntz, H. Sitter, K. H. Stadlbauer, and K. H. Lindner, "A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation, " The New England Journal of Medicine, vol. 350, no. 2, pp. 105-113, 2004.
30. K. H. Stadlbauer, H. G. Wagner-Berger, C. Raedler et al., "Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs, " Anesthesiology, vol. 98, no. 3, pp. 699-704, 2003.
31. E. Cavus, P. Meybohm, V. Doerges et al., "Cerebral effects of three resuscitation protocols in uncontrolled haemorrhagic shock: a randomised controlled experimental study, " Resuscitation, vol. 80, no. 5, pp. 567-572, 2009.
32. A. J. Feinstein, S. M. Cohn, D. R. King et al., "Early vasopressin improves short-termsurvival after pulmonary contusion, " Journal of Trauma-Injury, Infection and Critical Care, vol. 59, no. 4, pp. 876-883, 2005.
33. M. W. Dunser, A. J. Mayr, A. Tur et al., "Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors, " Critical Care Medicine, vol. 31, no. 5, pp. 1394-1398, 2003.
34. A. W. Prengel, K. H. Lindner, V. Wenzel, I. Tugtekin, and T. Anhaupl, "Splanchnic and renal blood flow after cardiopulmonary resuscitationwith epinephrine and vasopressin in pigs, " Resuscitation, vol. 38, no. 1, pp. 19-24, 1998.
35. J. Szmydynger-Chodobska, I. Chung, E. Kozniewska et al., "Increased expression of vasopressin V1a receptors after traumatic brain injury, " Journal of Neurotrauma, vol. 21, no. 8, pp. 1090-1102, 2004.
36. G. G. L. Biondi-Zoccai, P. Agostoni, A. Abbate, L. Testa, F. Burzotta, and K. A. Robinson, "A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials, " International Journal of Epidemiology, vol. 34, no. 1, pp. 224-225, 2005.
37. A. Zangrillo, G. G. L. Biondi-Zoccai, E. Frati et al., "Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials, " Journal of Cardiothoracic and Vascular Anesthesia, vol. 26, no. 3, pp. 407-413, 2012.
38. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, "Measuring inconsistency in meta-analyses, " The British Medical Journal, vol. 327, no. 7414, pp. 557-560, 2003.
39. L. Liu, K. Tian, M. Xue et al., "Small doses of arginine vasopressin in combination with norepinephrine "buy" time for definitive treatment for uncontrolled hemorrhagic shock in rats, " Shock, vol. 40, no. 5, pp. 398-406, 2013.
40. K. H. Stadlbauer, H. G. Wagner-Berger, A. C. Krismer et al., "Vasopressin improves survival in a porcine model of abdominal vascular injury, " Critical Care, vol. 11, article R81, 2007.
41. F. Beloncle, F. Meziani, N. Lerolle, P. Radermacher, and P. Asfar, "Does vasopressor therapy have an indication in hemorrhagic shock?" Annals of Intensive Care, vol. 3, no. 1, pp. 1-6, 2013.
42. G. Oliver and E. Schaefer, "On the physiological action of extract of pituitary body and certain other glandular organs, " Journal of Physiology, vol. 18, pp. 277-279, 1895.
43. D. W. Landry, H. R. Levin, E. M. Gallant et al., "Vasopressin pressor hypersensitivity in vasodilatory septic shock, " Critical Care Medicine, vol. 25, no. 8, pp. 1279-1282, 1997.
44. J. A. Russell, K. R. Walley, J. Singer et al., "Vasopressin versus norepinephrine infusion in patients with septic shock, "TheNew England Journal of Medicine, vol. 358, no. 9, pp. 877-887, 2008.
45. K. H. Lindner, T. Haak, A. Keller, U. Bothner, and K. G. Lurie, "Release of endogenous vasopressors during and after cardiopulmonary resuscitation, " Heart, vol. 75, no. 2, pp. 145-150, 1996.
46. K. H. Lindner, H. U. Strohmenger, H. Ensinger, W. D. Hetzel, F. W. Ahnefeld, and M. Georgieff, "Stress hormone response during and after cardiopulmonary resuscitation, " Anesthesiology, vol. 77, no. 4, pp. 662-668, 1992.
47. C. Thiemermann, C. Szabo, J. A. Mitchell, and J. R. Vane, "Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 1, pp. 267-271, 1993.
48. H. K. Eltzschig and P. Carmeliet, "Hypoxia and inflammation, " The New England Journal of Medicine, vol. 364, no. 7, pp. 656-665, 2011.
49. N. Smail, A. Descorps Declere, J. Duranteau, B. Vigue, and K. Samii, "Left ventricular function after severe trauma, " Intensive Care Medicine, vol. 22, no. 5, pp. 439-442, 1996.
50. D. S. Plurad, P. Talving, L. Lam, K. Inaba, D. Green, and D. Demetriades, "Early vasopressor use in critical injury is associated with mortality independent from volume status, " Journal of Trauma-Injury, Infection andCritical Care, vol. 71, no. 3, pp. 565-572, 2011.
51. R. M. Sharma and R. Setlur, "Vasopressin in hemorrhagic shock, " Anesthesia and Analgesia, vol. 101, no. 3, pp. 833-834, 2005.
52. H. G. Lienhart, V. Wenzel, J. Braun et al., "Vasopressin for therapy of persistent traumatic hemorrhagic shock: the VITRIS study, " Anaesthesist, vol. 56, no. 2, pp. 145-150, 2007.
53. B. Collier, L. Dossett, M. Mann et al., "Vasopressin use is associated with death in acute trauma patients with shock, " Journal of Critical Care, vol. 25, no. 1, pp. 173. e9-173. e14, 2010.
54. S. Grmec, M. Strnad, D. Cander, and S. Mally, "A treatment protocol including vasopressin and hydroxyethyl starch solution is associated with increased rate of return of spontaneous circulation in blunt trauma patients with pulseless electrical activity, " International Journal of EmergencyMedicine, vol. 1, no. 4, pp. 311-316, 2008.
55. E. Cavus, P. Meybohm, V. Doerges et al., "Effects of cerebral hypoperfusion on bispectral index: a randomised, controlled animal experiment during haemorrhagic shock, " Resuscitation, vol. 81, no. 9, pp. 1183-1189, 2010.
56. M. Dudkiewicz and K. G. Proctor, "Tissue oxygenation during management of cerebral perfusion pressure with phenylephrine or vasopressin, " Critical Care Medicine, vol. 36, no. 9, pp. 2641-2650, 2008.
57. P. Meybohm, E. Cavus, V. Dorges et al., "Release of protein S100B in haemorrhagic shock: effects of small volume resuscitation combined with arginine vasopressin, " Resuscitation, vol. 76, no. 3, pp. 449-456, 2008.
58. H. G. Lienhart, K. H. Lindner, andV. Wenzel, "Developing alternative strategies for the treatment of traumatic haemorrhagic shock, " Current Opinion in Critical Care, vol. 14, no. 3, pp. 247-253, 2008.
59. M. W. Dunser, A. J. Mayr, H. Ulmer et al., "The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis, " Anesthesia and Analgesia, vol. 93, no. 1, pp. 7-13, 2001.
60. M. W. Dunser, V. Wenzel, A. J. Mayr, and W. R. Hasibeder, "Management of vasodilatory shock: defining the role of arginine vasopressin, " Drugs, vol. 63, no. 3, pp. 237-256, 2003.
61. J. L. Sperry, J. P. Minei, H. L. Frankel et al., "Early use of vasopressors after injury: caution before constriction, " Journal of Trauma, vol. 64, no. 1, pp. 9-14, 2008.
62. F. Beloncle, F. Meziani, N. Lerolle, P. Radermacher, and P. Asfar, "Does vasopressor therapy have an indication in hemorrhagic shock?" Annals of Intensive Care, vol. 3, article 13, 2013.
63. R. R. Rajani, C. G. Ball, D. V. Feliciano, and G. A. Vercruysse, "Vasopressin in hemorrhagic shock: review article, " American Surgeon, vol. 75, no. 12, pp. 1207-1212, 2009.
64. H. M. Vesterinen, E. S. Sena, K. J. Egan et al., "Meta-analysis of data from animal studies: a practical guide, " Journal of Neuroscience Methods, vol. 221, no. 15, pp. 92-102, 2014.